// App-Quantinova.ai

2793 : ADP- dependent glucokinase enhances hypoxia- inducible factor- target gene transactivation through modulation of ROS levels in hypoxic human cancer cells

Researchers

Presenter

  • Sergio Rey

Principal Investigators

  • Luana Schito

  • Marianne Koritzinsky

  • Bradly G. Wouters

Medical Centers

  • Princess Margaret Cancer Center, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Proto-oncogene tyrosine-protein kinase ROS

  • Hypoxia-inducible factor-1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved